Aclarion, Inc. (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company, today announced the release of a new video featuring Mr. John Sutcliffe, Consultant Spinal Neurosurgeon at The London Clinic, one of the United Kingdom's leading private hospitals. The video, available here, showcases his experience using Nociscan to evaluate patients with chronic low back pain.
With over 30 years of experience, Mr. Sutcliffe also serves as Lead Clinician at The London Spine Clinic and is frequently referred complex spinal cases. In the video, he notes that Nociscan provides an additional layer of insight that complements traditional imaging, offering objective data to inform clinical decisions and improve confidence.
To date, nearly 100 Nociscans have been conducted at The London Clinic. Nociscan is a non-invasive solution that differentiates painful from non-painful discs in the lumbar spine using MR spectroscopy and proprietary signal processing to identify chemical biomarkers associated with disc pain. This sustained use reflects growing integration into routine clinical practice.
Brent Ness, CEO of Aclarion, stated, “Approaching 100 scans at a leading international center like The London Clinic is an important indicator of increasing adoption and reinforces the potential for Nociscan to become a valuable tool in the evaluation of chronic low back pain.”
Chronic low back pain affects approximately 266 million people worldwide. When used alongside other diagnostic tools, clinical data has demonstrated up to a 97% surgical success rate when all Nociscan-positive discs are treated. For more information, visit Aclarion's website or view the latest news here.
